产品名称
SUPELCOSIL™ LC-18-DB Supelguard 柱芯, 5 μm particle size, L × I.D. 2 cm × 4 mm
Quality Level
packaging
pkg of 1 kit
technique(s)
HPLC: suitable
L × I.D.
2 cm × 4 mm
matrix active group
C18 (octadecyl) phase
particle size
5 μm
application(s)
food and beverages
separation technique
reversed phase
General description
SUPELCOSIL™ LC-18-DB Supelguard Cartridges [5 μm particle size, L × I.D. 2 cm × 4 mm] contain a SUPELCOSIL packing, in a 2 cm stainless steel body, enclosed by polyether ether ketone (PEEK) encapsulated stainless steel frits (2 μm porosity). A Supelguard kit (one cartridge, a stand-alone holder, tubing, and 2 nuts and ferrules) enables one to use the cartridge with any analytical column. A direct-connect guard cartridge holder can directly connect a Supelguard cartridge to a Supelco analytical column. 3.0 mm cartridges are available in packs of two only-purchase a stand-alone or modular holder separately. Low volume 3.0 mm ID cartridges are a good choice for protecting an analytical column containing 3 μm particles.
Other Notes
套装包括一个保护柱芯、一个独立式柱套、一根连接管、2 个接头螺母与密封垫圈。
Legal Information
SUPELCOSIL is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under SUPELCOSIL™ LC-18-DB Supelguard 柱芯
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
O Majid et al.
Therapeutic drug monitoring, 23(2), 163-168 (2001-04-11)
Recipients of organ transplants remain particularly dependent on prednisolone as part of their maintenance immunosuppression. Despite this, the pharmacokinetics of prednisolone have never been fully characterized in these patients, and consequently dosing remains empirical. Accurate monitoring of prednisolone, its primary
S L Bramer et al.
Journal of pharmaceutical and biomedical analysis, 26(4), 637-650 (2001-08-23)
An LC/MS/MS method for the simultaneous determination of cilostazol, a quinolinone derivative, and three active metabolites, OPC-13015, OPC-13213, and OPC-13217, in human plasma was developed and validated. Cilostazol, its metabolites, and the internal standard, OPC-3930 were extracted from human plasma
E Terjéki et al.
Journal of pharmaceutical and biomedical analysis, 24(5-6), 913-920 (2001-03-15)
RGH-1756 (1-(2-methoxy-phenyl)-4-(4-[4-(6-imidazo[2,1-b]-thiazolyl)-phenoxy]-butyl)-piperazine dimethansulphonate) is a novel atypical antipsychotic candidate of Gedeon Richter Ltd. A new HPLC method has been developed and validated for the quantitative determination of RGH-1756 in dog and rat plasma. The compound and the internal standard are
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 59555 | 04061833670361 |